Jill Broadfoot | CFO |
Sanjay Shukla | CEO |
Shawn Egan | Citi |
Katherine Xu | William Blair |
Good afternoon, ladies and gentlemen and welcome to the aTyr Pharma's fourth quarter and full 2018 conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time.
As a reminder to our audience, this conference is being recorded for replay purposes. It is now my pleasure to hand the conference over to Jill Broadfoot, aTyr's Chief Financial Officer.